Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Utipro Plus AF
- Development stage
- Unknown
- Lead developer
- Noventure
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Utipro Plus AF is an oral combination product developed for the control and prevention of urinary tract infections (UTIs), particularly those caused by *Escherichia coli* and other Gram-negative bacteria. It is classified as a Class IIa medical device in the European Union but is used therapeutically to manage both acute and recurrent UTIs. The product contains a unique combination of xyloglucan, gelose (gelatin), propolis, and *Hibiscus sabdariffa*. Its primary mechanism of action is the formation of a physical bio-protective film on the intestinal mucosa, which prevents the adhesion and proliferation of pathogens in the gut, thereby blocking their migration to the urinary tract. Additionally, the propolis and hibiscus components work to acidify the urine, creating an environment that inhibits bacterial growth within the bladder.
- Brand names
- Utipro Plus AFUtipro Plus
- Other names
- Xyloglucan + Gelose + Propolis + Hibiscus sabdariffa
Beyond the preview
Go deeper on Utipro Plus AF.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Utipro Plus AF.